SCHEMBL18032007

SCHEMBL18032007

CCN=NN=NN=NN=NN=NN=NCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19559643 0.83 — —
SCHEMBL14668160 0.83 — —
SCHEMBL16691064 0.83 — —
SCHEMBL19174467 0.83 — —
SCHEMBL14524688 0.83 — —
SCHEMBL9070160 0.81 — —
SCHEMBL14617991 0.78 — —
SCHEMBL13713072 0.76 — —
SCHEMBL769165 0.75 — —
SCHEMBL769166 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160243259-A1 POLYNUCLEOTIDE COMPOSITIONS CONTAINING AMINO ACIDS ARES CAPITAL CORPORATION, AS AGENT 2016-08-25 — — US disclosed
US-20160243221-A1 COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS MODERNA THERAPEUTICS, INC. (US) 2016-08-25 — — US disclosed
Send feedback